![Euroapi Company Header](https://www.pharmacompass.com/image/flap/euroapi-corp-ad-w30-desktop-header-1-2gif-57087.gif)
![Euroapi Company Header](https://www.pharmacompass.com/image/flap/euro-api-mob-header-w30gif-19381.gif)
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://endpts.com/incarda-terminates-phiii-trial-of-its-inhaled-atrial-fibrillation-drug/
https://www.fiercebiotech.com/cro/incarda-physiq-and-syneos-team-phase-3-flecainide-study
https://www.biospace.com/article/-incarda-therapeutics-provides-corporate-update-highlighting-new-phase-2-data-for-inrhythm-program-plans-for-pivotal-phase-3-study-and-expansion-of-senior-management-team/
https://endpts.com/with-its-eyes-set-on-an-ipo-raise-incarda-preps-to-unroll-mid-stage-data-backing-inhaled-arrhythmia-drug/
https://www.globenewswire.com/news-release/2021/06/09/2244357/0/en/InCarda-Therapeutics-Provides-Corporate-Update-Highlighting-New-Phase-2-Data-for-InRhythm-Program-Plans-for-Pivotal-Phase-3-Study-and-Expansion-of-Senior-Management-Team.html